Prestwick Chemical Overview

  • Year Founded
  • 1999

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 26

Employees

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 2

Prestwick Chemical General Information

Description

Provider of medicinal chemistry services intended to ensure a high hit rate. The company's portfolio of smart libraries is designed to ensure maximal chemical diversity, possibly to access new IP while remaining within reach of both low and high-throughput screening processes, helping clients to optimize the chance of success in hit finding using fragment-based drug discovery.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 220 Boulevard Gonthier d'Andernach
  • Parc d'innovation
  • 67400 Illkirch
  • France
+33 03
Primary Industry
Drug Discovery
Parent Company
Vertical(s)
Corporate Office
  • 220 Boulevard Gonthier d'Andernach
  • Parc d'innovation
  • 67400 Illkirch
  • France
+33 03

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Prestwick Chemical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Prestwick Chemical‘s full profile, request access.

Request a free trial

Prestwick Chemical Patents

Prestwick Chemical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20250002448-A1 Allosteric modulators of nicotinic acetylcholine receptors Pending 21-Sep-2021
US-20220119351-A1 Spiropiperidine allosteric modulators of nicotinic acetylcholine receptors Pending 02-May-2019
US-9994518-B2 Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof Active 13-Jun-2014
US-20170152221-A1 Alpha-7 nicotinic acetylcholine receptor modulators and uses thereof Active 13-Jun-2014
US-20150175534-A1 Alpha-7 nicotinic acetylcholine receptor modulators and uses therof-i Inactive 01-Aug-2012 C07C311/37
To view Prestwick Chemical’s complete patent history, request access »

Prestwick Chemical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Prestwick Chemical Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Prestwick Chemical‘s full profile, request access.

Request a free trial

Prestwick Chemical FAQs

  • When was Prestwick Chemical founded?

    Prestwick Chemical was founded in 1999.

  • Where is Prestwick Chemical headquartered?

    Prestwick Chemical is headquartered in Illkirch, France.

  • What is the size of Prestwick Chemical?

    Prestwick Chemical has 26 total employees.

  • What industry is Prestwick Chemical in?

    Prestwick Chemical’s primary industry is Drug Discovery.

  • Is Prestwick Chemical a private or public company?

    Prestwick Chemical is a Private company.

  • What is Prestwick Chemical’s current revenue?

    The current revenue for Prestwick Chemical is .

  • Who are Prestwick Chemical’s investors?

    Bionomics has invested in Prestwick Chemical.

  • When was Prestwick Chemical acquired?

    Prestwick Chemical was acquired on 03-Mar-2020.

  • Who acquired Prestwick Chemical?

    Prestwick Chemical was acquired by Domain Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »